Related Experiment Video
Updated: Jul 15, 2026
05:18
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
[Guidelines and malpractice in obesity treatment].
A De Lorenzo1, C Maiolo, G D'Agostino
1Cattedra di Alimentazione e Nutrizione Umana, Dipartimento di Neuroscienze, Facoltà di Medicina e Chirurgia, Università "Tor Vergata", Roma, Italia. delorenzo@uniroma2.it
La Clinica Terapeutica
|July 5, 2006
Summary
Obesity is a common nutritional disorder linked to serious health issues. Current measurement methods like BMI have limitations, and obesity management can lead to complications.
Area of Science:
- Nutritional Science
- Endocrinology
- Public Health
Context:
- Obesity is a prevalent nutritional disorder in developed nations.
- It is associated with numerous comorbidities, including type 2 diabetes mellitus, hypertension, hyperlipidemias, cholelithiasis, obstructive sleep apneas, coronary heart disease, and cancer.
Purpose:
- To review the limitations of current obesity measurement techniques.
- To highlight potential complications and errors associated with obesity management strategies.
Summary:
- Body mass index (BMI) is a common but imprecise measure of obesity, failing to accurately predict body fat content.
- Specialized methods such as skin-fold thickness, bioelectrical impedance analysis, and dual-energy x-ray absorptiometry offer more specific body composition analysis but require extensive reference databases.
- Obesity management, encompassing dietary interventions, weight loss monitoring, pharmacotherapy, and surgical options, is frequently complicated by adverse events and inaccuracies.
Impact:
- Highlights the need for improved obesity assessment tools.
- Underscores the challenges and risks inherent in clinical obesity management.
- Informs healthcare providers about the complexities of addressing obesity and its associated health risks.
Related Concept Videos
01:06Legal Guidelines for Documentation
The legal guidelines for nursing documentation are essential for ensuring accurate, professional, and ethical recording of patient care. The guidelines are discussed here:
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...